MK-1903 |
An HCA2 receptor agonist (EC50 = 12.9 nM in an HTRF assay); selective for… |
5 mg |
34304-5 |
More Info
|
MK-2461 |
A c-MET inhibitor (IC50s = 0.4-2 nM for wild-type and mutant forms); selec… |
1 mg |
32964-1 |
More Info
|
MK-2461 |
A c-MET inhibitor (IC50s = 0.4-2 nM for wild-type and mutant forms); selec… |
10 mg |
32964-10 |
More Info
|
MK-2461 |
A c-MET inhibitor (IC50s = 0.4-2 nM for wild-type and mutant forms); selec… |
5 mg |
32964-5 |
More Info
|
MK-3102 |
A DPP-4 inhibitor (IC50 = 1.6 nM); selective for DPP-4 over several protea… |
1 mg |
21454-1 |
More Info
|
MK-3102 |
A DPP-4 inhibitor (IC50 = 1.6 nM); selective for DPP-4 over several protea… |
10 mg |
21454-10 |
More Info
|
MK-3102 |
A DPP-4 inhibitor (IC50 = 1.6 nM); selective for DPP-4 over several protea… |
25 mg |
21454-25 |
More Info
|
MK-3102 |
A DPP-4 inhibitor (IC50 = 1.6 nM); selective for DPP-4 over several protea… |
5 mg |
21454-5 |
More Info
|
MK-3697 |
An orexin receptor 2 antagonist (Ki = 1.1 nM); selective for OX2R over OX1… |
10 mg |
34718-10 |
More Info
|
MK-3697 |
An orexin receptor 2 antagonist (Ki = 1.1 nM); selective for OX2R over OX1… |
25 mg |
34718-25 |
More Info
|
MK-3697 |
An orexin receptor 2 antagonist (Ki = 1.1 nM); selective for OX2R over OX1… |
5 mg |
34718-5 |
More Info
|
MK-3697 |
An orexin receptor 2 antagonist (Ki = 1.1 nM); selective for OX2R over OX1… |
50 mg |
34718-50 |
More Info
|
MK-3903 |
An AMPK activator (EC50 = 9 nM); selective for AMPK over a kinase panel at… |
1 mg |
29661-1 |
More Info
|
MK-3903 |
An AMPK activator (EC50 = 9 nM); selective for AMPK over a kinase panel at… |
10 mg |
29661-10 |
More Info
|
MK-3903 |
An AMPK activator (EC50 = 9 nM); selective for AMPK over a kinase panel at… |
25 mg |
29661-25 |
More Info
|
MK-3903 |
An AMPK activator (EC50 = 9 nM); selective for AMPK over a kinase panel at… |
5 mg |
29661-5 |
More Info
|
MK-4101 |
A Smoothened receptor antagonist; binds to human recombinant Smo expressed… |
1 mg |
29159-1 |
More Info
|
MK-4101 |
A Smoothened receptor antagonist; binds to human recombinant Smo expressed… |
10 mg |
29159-10 |
More Info
|
MK-4101 |
A Smoothened receptor antagonist; binds to human recombinant Smo expressed… |
25 mg |
29159-25 |
More Info
|
MK-4101 |
A Smoothened receptor antagonist; binds to human recombinant Smo expressed… |
5 mg |
29159-5 |
More Info
|
MK-5108 |
A potent inhibitor of Aurora A (IC50 = 0.064 nM) that less potently inhibi… |
1 mg |
19167-1 |
More Info
|
MK-5108 |
A potent inhibitor of Aurora A (IC50 = 0.064 nM) that less potently inhibi… |
10 mg |
19167-10 |
More Info
|
MK-5108 |
A potent inhibitor of Aurora A (IC50 = 0.064 nM) that less potently inhibi… |
5 mg |
19167-5 |
More Info
|
MK-571 |
A CysLT1 receptor antagonist (Ki = 2.1 nM in a radioligand binding assay u… |
1 mg |
10029-1 |
More Info
|
MK-571 |
A CysLT1 receptor antagonist (Ki = 2.1 nM in a radioligand binding assay u… |
10 mg |
10029-10 |
More Info
|
MK-571 |
A CysLT1 receptor antagonist (Ki = 2.1 nM in a radioligand binding assay u… |
5 mg |
10029-5 |
More Info
|
MK-571 |
A CysLT1 receptor antagonist (Ki = 2.1 nM in a radioligand binding assay u… |
50 mg |
10029-50 |
More Info
|
MK6-83 |
A TRPML1 activator (EC50s = 110, 100, and 1,230 nM in wild type, F465L, an… |
1 mg |
21944-1 |
More Info
|
MK6-83 |
A TRPML1 activator (EC50s = 110, 100, and 1,230 nM in wild type, F465L, an… |
10 mg |
21944-10 |
More Info
|
MK6-83 |
A TRPML1 activator (EC50s = 110, 100, and 1,230 nM in wild type, F465L, an… |
25 mg |
21944-25 |
More Info
|
MK6-83 |
A TRPML1 activator (EC50s = 110, 100, and 1,230 nM in wild type, F465L, an… |
5 mg |
21944-5 |
More Info
|
MK-7246 |
A CRTH2 / DP2 receptor antagonist (Ki = 2.5 nM); selective for CRTH2 / DP2… |
1 mg |
34208-1 |
More Info
|
MK-7246 |
A CRTH2 / DP2 receptor antagonist (Ki = 2.5 nM); selective for CRTH2 / DP2… |
10 mg |
34208-10 |
More Info
|
MK-7246 |
A CRTH2 / DP2 receptor antagonist (Ki = 2.5 nM); selective for CRTH2 / DP2… |
25 mg |
34208-25 |
More Info
|
MK-7246 |
A CRTH2 / DP2 receptor antagonist (Ki = 2.5 nM); selective for CRTH2 / DP2… |
5 mg |
34208-5 |
More Info
|
MK-7622 |
A positive allosteric modulator of M1 mAChRs; increases ACh-induced calciu… |
10 mg |
34407-10 |
More Info
|
MK-7622 |
A positive allosteric modulator of M1 mAChRs; increases ACh-induced calciu… |
25 mg |
34407-25 |
More Info
|
MK-7622 |
A positive allosteric modulator of M1 mAChRs; increases ACh-induced calciu… |
5 mg |
34407-5 |
More Info
|
MK-7622 |
A positive allosteric modulator of M1 mAChRs; increases ACh-induced calciu… |
50 mg |
34407-50 |
More Info
|
MK-7655 |
A β-lactamase inhibitor; inhibits hydrolysis of nitrocefin by KPC-2 &… |
1 mg |
23890-1 |
More Info
|
MK-7655 |
A β-lactamase inhibitor; inhibits hydrolysis of nitrocefin by KPC-2 &… |
10 mg |
23890-10 |
More Info
|
MK-7655 |
A β-lactamase inhibitor; inhibits hydrolysis of nitrocefin by KPC-2 &… |
25 mg |
23890-25 |
More Info
|
MK-7655 |
A β-lactamase inhibitor; inhibits hydrolysis of nitrocefin by KPC-2 &… |
5 mg |
23890-5 |
More Info
|
MK-8245 |
A stearoyl-CoA desaturase inhibitor (IC50s = 3, 3, and 1 nM for rat , mous… |
1 mg |
29421-1 |
More Info
|
MK-8245 |
A stearoyl-CoA desaturase inhibitor (IC50s = 3, 3, and 1 nM for rat , mous… |
10 mg |
29421-10 |
More Info
|
MK-8245 |
A stearoyl-CoA desaturase inhibitor (IC50s = 3, 3, and 1 nM for rat , mous… |
25 mg |
29421-25 |
More Info
|
MK-8245 |
A stearoyl-CoA desaturase inhibitor (IC50s = 3, 3, and 1 nM for rat , mous… |
5 mg |
29421-5 |
More Info
|
MK-8617 |
A HIF-PH1, -2, and -3 inhibitor (IC50s = 1, 1, and 14 nM, respectively); s… |
100 mg |
33790-100 |
More Info
|
MK-8617 |
A HIF-PH1, -2, and -3 inhibitor (IC50s = 1, 1, and 14 nM, respectively); s… |
25 mg |
33790-25 |
More Info
|
MK-8617 |
A HIF-PH1, -2, and -3 inhibitor (IC50s = 1, 1, and 14 nM, respectively); s… |
5 mg |
33790-5 |
More Info
|